198 related articles for article (PubMed ID: 31371346)
1. Molecular heterogeneity of the cerebriform connective tissue nevus in mosaic overgrowth syndromes.
Keppler-Noreuil KM; Burton-Akright J; Lindhurst MJ; Shwetar J; Sapp JC; Darling T; Biesecker LG
Cold Spring Harb Mol Case Stud; 2019 Aug; 5(4):. PubMed ID: 31371346
[TBL] [Abstract][Full Text] [Related]
2. Late-onset Proteus syndrome with cerebriform connective tissue nevus and subsequent development of intraductal papilloma.
Modlin EW; Slavotinek AM; Darling TN; Lipkowitz S; Barr FG; Munster PN; Biesecker LG; Ours CA
Am J Med Genet A; 2022 Sep; 188(9):2766-2771. PubMed ID: 35441778
[TBL] [Abstract][Full Text] [Related]
3. Dermatologic findings in individuals with genetically confirmed Proteus syndrome.
Pithadia DJ; Cartron AM; Biesecker LG; Darling TN
Pediatr Dermatol; 2021 Jul; 38(4):794-799. PubMed ID: 34105192
[TBL] [Abstract][Full Text] [Related]
4. A limited form of proteus syndrome with bilateral plantar cerebriform collagenomas and varicose veins secondary to a mosaic AKT1 mutation.
Wee JS; Mortimer PS; Lindhurst MJ; Chong H; Biesecker LG; Holden CA
JAMA Dermatol; 2014 Sep; 150(9):990-3. PubMed ID: 24850616
[TBL] [Abstract][Full Text] [Related]
5. Molecular Diagnosis of Mosaic Overgrowth Syndromes Using a Custom-Designed Next-Generation Sequencing Panel.
Chang F; Liu L; Fang E; Zhang G; Chen T; Cao K; Li Y; Li MM
J Mol Diagn; 2017 Jul; 19(4):613-624. PubMed ID: 28502725
[TBL] [Abstract][Full Text] [Related]
6. Pathogenetic insights from quantification of the cerebriform connective tissue nevus in Proteus syndrome.
Nathan NR; Patel R; Crenshaw MM; Lindhurst MJ; Olsen C; Biesecker LG; Keppler-Noreuil KM; Darling TN
J Am Acad Dermatol; 2018 Apr; 78(4):725-732. PubMed ID: 29042227
[TBL] [Abstract][Full Text] [Related]
7. Proteus syndrome review: molecular, clinical, and pathologic features.
Cohen MM
Clin Genet; 2014 Feb; 85(2):111-9. PubMed ID: 23992099
[TBL] [Abstract][Full Text] [Related]
8. Molecular diagnosis of somatic overgrowth conditions: A single-center experience.
Lalonde E; Ebrahimzadeh J; Rafferty K; Richards-Yutz J; Grant R; Toorens E; Marie Rosado J; Schindewolf E; Ganguly T; Kalish JM; Deardorff MA; Ganguly A
Mol Genet Genomic Med; 2019 Mar; 7(3):e536. PubMed ID: 30761771
[TBL] [Abstract][Full Text] [Related]
9. High-level somatic mosaicism of AKT1 c.49G>A mutation in skin scrapings from epidermal nevi enables non-invasive molecular diagnosis in patients with Proteus syndrome.
Wieland I; Tinschert S; Zenker M
Am J Med Genet A; 2013 Apr; 161A(4):889-91. PubMed ID: 23436452
[No Abstract] [Full Text] [Related]
10. [A clinical study of Proteus syndrome caused by a mosaic somatic mutation in AKT1 gene].
Xu Y; Fu WZ; He JW; Yue H; Zhang ZL
Zhonghua Nei Ke Za Zhi; 2019 Jul; 58(7):508-513. PubMed ID: 31269567
[No Abstract] [Full Text] [Related]
11. Proteus Syndrome: Case Report with Anatomopathological Correlation.
Arredondo Montero J; Bronte Anaut M; López-Gutiérrez JC
Fetal Pediatr Pathol; 2022 Oct; 41(5):861-864. PubMed ID: 34668833
[No Abstract] [Full Text] [Related]
12. Proteus syndrome: an update.
Cohen MM
Am J Med Genet C Semin Med Genet; 2005 Aug; 137C(1):38-52. PubMed ID: 16010681
[TBL] [Abstract][Full Text] [Related]
13. Allelic heterogeneity of Proteus syndrome.
Buser A; Lindhurst MJ; Kondolf HC; Yourick MR; Keppler-Noreuil KM; Sapp JC; Biesecker LG
Cold Spring Harb Mol Case Stud; 2020 Jun; 6(3):. PubMed ID: 32327430
[TBL] [Abstract][Full Text] [Related]
14. Overgrowth Syndromes Caused by Somatic Variants in the Phosphatidylinositol 3-Kinase/AKT/Mammalian Target of Rapamycin Pathway.
Akgumus G; Chang F; Li MM
J Mol Diagn; 2017 Jul; 19(4):487-497. PubMed ID: 28502730
[TBL] [Abstract][Full Text] [Related]
15. A dyadic genotype-phenotype approach to diagnostic criteria for Proteus syndrome.
Sapp JC; Buser A; Burton-Akright J; Keppler-Noreuil KM; Biesecker LG
Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):565-570. PubMed ID: 31692258
[TBL] [Abstract][Full Text] [Related]
16. Fibroadipose hyperplasia versus Proteus syndrome: segmental overgrowth with a mosaic mutation in the PIK3CA gene.
Youssefian L; Vahidnezhad H; Baghdadi T; Ghaznavi A; Li Q; Tabrizi M; Uitto J
J Invest Dermatol; 2015 May; 135(5):1450-1453. PubMed ID: 25602158
[No Abstract] [Full Text] [Related]
17. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum.
Keppler-Noreuil KM; Sapp JC; Lindhurst MJ; Parker VE; Blumhorst C; Darling T; Tosi LL; Huson SM; Whitehouse RW; Jakkula E; Grant I; Balasubramanian M; Chandler KE; Fraser JL; Gucev Z; Crow YJ; Brennan LM; Clark R; Sellars EA; Pena LD; Krishnamurty V; Shuen A; Braverman N; Cunningham ML; Sutton VR; Tasic V; Graham JM; Geer J; Henderson A; Semple RK; Biesecker LG
Am J Med Genet A; 2014 Jul; 164A(7):1713-33. PubMed ID: 24782230
[TBL] [Abstract][Full Text] [Related]
18. Progressive overgrowth of the cerebriform connective tissue nevus in patients with Proteus syndrome.
Beachkofsky TM; Sapp JC; Biesecker LG; Darling TN
J Am Acad Dermatol; 2010 Nov; 63(5):799-804. PubMed ID: 20709429
[TBL] [Abstract][Full Text] [Related]
19. Fronto-temporal cerebriform connective tissue nevus in Proteus syndrome.
Balaji SM
Indian J Dent Res; 2014; 25(6):828-31. PubMed ID: 25728123
[TBL] [Abstract][Full Text] [Related]
20. What's New in Genetic Skin Diseases.
Hill CR; Theos A
Dermatol Clin; 2019 Apr; 37(2):229-239. PubMed ID: 30850045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
